Skip to content

Deals
Sectors
- Aerospace
- AI
- Blockchain
- Climate
- Consumer
- Education
- Entertainment
- Fintech
- Healthcare
- Internet
- Mobility
- Smart Hardware
- VR/AR
Insights
中文版

Deals
Sectors
- Aerospace
- AI
- Blockchain
- Climate
- Consumer
- Education
- Entertainment
- Fintech
- Healthcare
- Internet
- Mobility
- Smart Hardware
- VR/AR
Insights
中文版

Search

Shenzhen Capital Group Company

Healthcare

SCGC-Backed Innovative Antibody Drug Firm Gets $150M Funding From Sino Biopharm

November 5, 2019 — 10:54

Home
About Us
Contact Us
Privacy
Terms & Conditions

Home
About Us
Contact Us
Privacy
Terms & Conditions

© 2025 China Money Network. All Rights Reserved. Disclaimer: The views, opinions, forecasts, and statements made by our hosts and guests are the personal views of those respective individuals and may or may not be either endorsed or accepted by China Money Network Limited or the companies with which these individuals are employed.